Pediatric - V Scholar Cancer Research Grant: The Pediatric V Scholar Award supports young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based discovery research or translational research.
Pediatric -Translational Cancer Research Grant: The V Foundation seeks to support translational research projects within the scope of pediatric cancer research. Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new pediatric clinical trial.
Each invited institution may submit one nominee to apply for this pediatric call.
The SOLE nominee may apply in either the V Scholar or Translational program type.
Deadlines:
Only DCI Members are eligible to apply.
Pediatric - V Scholar Cancer Research Grant:
• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US. This requirement does not apply to invited Canadian institutions.
• Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
• Clinical scientists are eligible if the research institution can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
Pediatric -Translational Cancer Research Grant:
Your nominee must be the lead Principal Investigator (PI) on the Pediatric Translational research team and must meet all of the following criteria:
• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or have a legal permit (temporary or permanent) to work in the US. This requirement does not apply to invited Canadian institutions.
• Hold a tenure-track or tenured faculty position at their cancer research institution. Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
The Translational Research Award is a $600,000 grant paid in three annual installments of $200,000. Indirect costs up to 10% are permitted (i.e., over the grant term, a maximum of $60,000 can be utilized for indirect costs leaving $540,000 for direct costs).
DCI will be conducting an internal review of applications. The following items are required and will be reviewed by the DCI’s Scientific Review Committee.
To be considered for nomination, the following should be submitted to Karen Judge at karen.judge@duke.edu by Feb. 9, 2022.
